Results 151 to 160 of about 87,721 (247)
Back Again to the Future: A New Era for Cerebroprotection
Cerebroprotection is a fresh framework for designing neurological therapy that targets glia and vascular cells, in addition to neurons. In the future, successful cerebroprotection will involve targeting all elements of the neurovascular unit. Preclinical trials must include functional outcomes, as well as lesion morphometry.
Patrick Lyden
wiley +1 more source
Correction: Assessing motor development with wearables in low-resource settings: feasibility in rural Malawi. [PDF]
Taylor E +7 more
europepmc +1 more source
Objective An enduring puzzle in many inherited neurological disorders is the late onset of symptoms despite expression of function‐impairing mutant protein early in life. We examined the basis for onset of impairment in spinocerebellar ataxia type 6 (SCA6), a canonical late‐onset neurodegenerative ataxia which results from a polyglutamine expansion in ...
Haoran Huang +10 more
wiley +1 more source
Asymptomatic tarsal tunnel syndrome in rheumatoid Arthritis: An electrophysiological perspective with insights into clinical and laboratory correlates. [PDF]
Elshony H +8 more
europepmc +1 more source
Circadian Mechanisms Underlying Reward-Related Neurophysiology and Synaptic Plasticity [PDF]
Puja K. Parekh, Colleen A. McClung
openalex +1 more source
Objectives Multiple sclerosis (MS) onset risk factors include Epstein–Barr virus (EBV) indices (including host response), lower serum 25‐vitamin D (25(OH)D) levels, low sun exposure, and HLA‐DRB1*1501. The underlying molecular mechanisms are unclear. Here, we examined mediation through differential DNA methylation (DNAm) to better understand possible ...
Steve Simpson‐Yap +37 more
wiley +1 more source

